4//SEC Filing
Gergen Mark J 4
Accession 0000950170-25-001527
CIK 0001661460other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:24 PM ET
Size
5.0 KB
Accession
0000950170-25-001527
Insider Transaction Report
Form 4
Gergen Mark J
DirectorExecutive Chairman
Transactions
- Tax Payment
Common Stock
2025-01-02$9.60/sh−23,313$223,805→ 630,726 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 2, 2024.
- [F2]Includes 2,748 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan (the "ESPP") on January 2, 2025.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001373110
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:24 PM ET
- Size
- 5.0 KB